US Stock MarketDetailed Quotes
ELEV Elevation Oncology
- 0.631
- +0.005+0.75%
Trading Nov 27 10:57 ET
37.28MMarket Cap-788P/E (TTM)
0.637High0.624Low45.88KVolume0.637Open0.626Pre Close28.95KTurnover0.11%Turnover RatioLossP/E (Static)59.12MShares5.83052wk High0.54P/B26.50MFloat Cap0.44052wk Low--Dividend TTM42.02MShs Float16.220Historical High--Div YieldTTM1.95%Amplitude0.363Historical Low0.630Avg Price1Lot Size
About Elevation Oncology Company
Elevation Oncology, Inc. is a precision oncology company, which engages in the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in Boston, MA.
Company Profile
SymbolELEV
Company NameElevation Oncology
Listing DateJun 25, 2021
Issue Price16.00
Founded2019
CEOMr. Joseph J. Ferra, Jr
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address101 Federal Street,Suite 1900,12th Floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02110
Phone1-716-371-1125
Company Executives
- Name
- Position
- Salary
- Joseph J. Ferra, Jr
- President, Chief Executive Officer and Director
- 1.24M
- Valerie Malyvanh Jansen
- Chief Medical Officer
- 836.06K
- Tammy Furlong
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. David Dornan, PhD
- Chief Scientific Officer
- 771.04K
- Steven A. Elms
- Chairman of the Board
- 113.08K
- R. Michael Carruthers
- Independent Director
- 86.48K
- Dr. Darcy Mootz, PhD
- Independent Director
- --
- Dr. Alan B. Sandler, M.D.
- Independent Director
- --
- Dr. Timothy P. Clackson,PhD
- Independent Director
- 84.48K
- Julie M. Cherrington, PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data